Long-term efficacy and safety of renal denervation: an update from registries and randomised trials
Hypertension remains the leading treatable global cause of mortality due to high incidence and poor control rates despite of safe and effective drug therapy. Animal studies do not support functional nerve regrowth after RF-RDN and accordingly clinical evidence verify that RDN leads to durable BP red...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Blood Pressure |
| Online Access: | http://dx.doi.org/10.1080/08037051.2023.2266664 |